6-(3,7,11,15,19,23-六甲基二十四烷基)-5-甲硫基苯并(b)噻吩-4,7-苯醌 | 63693-26-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 6-(3,7,11,15,19,23-六甲基二十四烷基)-5-甲硫基苯并(b)噻吩-4,7-苯醌
• 英文名称: Caldariellaquinone
• 英文别名: 6-(3,7,11,15,19,23-hexamethyltetracosyl)-5-methylsulfanyl-1-benzothiophene-4,7-dione
• CAS: 63693-26-5
• 化学式: C₃₉H₆₆O₂S₂
• 分子量: 631.1
• InChiKey: GHRWXPXOBGRSHG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  16.4
• 重原子数：
  43
• 可旋转键数：
  24
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.79
• 拓扑面积：
  87.7
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Processes and host cells for genome, pathway, and biomolecular engineering
  申请人：enEvolv, Inc.

  公开号：US10370654B2

  公开（公告）日：2019-08-06

  The present disclosure provides compositions and methods for genomic engineering.

  本公开提供了基因组工程的组合物和方法。
• DRUG-CONTAINING COMPOSITION
  申请人：Nakamura Kentaro

  公开号：US20110009497A1

  公开（公告）日：2011-01-13

  It is an object of the present invention to provide a drug-containing composition which is capable of dissolving a poorly water-soluble drug, has low toxicity to the human body, and has high binding affinity with drugs. The present invention provides a composition which is composed of: (a) at least one poorly water-soluble compound; and (b) a carrier comprising a polymer (excluding plasma protein) having binding affinity with the poorly water-soluble compound.
• PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING
  申请人：ENEVOLV, INC.

  公开号：US20160186168A1

  公开（公告）日：2016-06-30

  The present disclosure provides compositions and methods for genomic engineering.
• US9944925B2
  申请人：——

  公开号：US9944925B2

  公开（公告）日：2018-04-17